Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies.

Acute myeloid leukemia (AML) is a heterogeneous blood-related neoplasm that predominantly afflicts older adults with a poor prognosis due to their physical condition and the presence of medical accompanying comorbidities, adverse biological disease features, and suitability for induction intensive c...

Descripción completa

Detalles Bibliográficos
Publicado en:	Current Oncology Vol. 31; no. 11; pp. 6632 - 6659
Autores principales:	Niscola, Pasquale, Gianfelici, Valentina, Catalano, Gianfranco, Giovannini, Marco, Mazzone, Carla, Noguera, Nelida Ines, de Fabritiis, Paolo
Formato:	Journal Article
Publicado:	MDPI Nov2024
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Sumario:	Acute myeloid leukemia (AML) is a heterogeneous blood-related neoplasm that predominantly afflicts older adults with a poor prognosis due to their physical condition and the presence of medical accompanying comorbidities, adverse biological disease features, and suitability for induction intensive chemotherapy and allogenic stem cells transplantation. Recent research into the molecular and biological factors contributing to disease development and progression has led to significant advancements in treatment approaches for older patients with AML. This review article discusses the latest biological and therapeutic developments that are transforming the management of AML in older adults.